About Index Trending news
Lists
Pricing
Abeona Therapeutics

Abeona Therapeutics

Abeona Therapeutics

Abeona is developing therapies for children with rare lysosomal diseases for the deadly childhood diseases Sanfilippo (SF) Syndrome Type A and TypeB.

Elsewhere

Contributors to this profile

Alexa global traffic share

Latest funding Show all
Post-IPO equity
$92,000,000
Venture capital
$8,500,000
Employees

Unknown size

Locations
HQ
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Abeona Therapeutics makes some noise.